Search Results for: CLINICAL TRIALS Accelerating the Clinical
Articles
SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Specialized Capabilities for Small & Large Molecules June 4, 2020
Contributor Cindy H. Dubin interviews key players in the CDMO market who present case studies about how they are helping pharmaceutical and biopharma companies overcome a variety of formulation and manufacturing challenges.
Thermo Fisher Scientific & CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services June 2, 2020
Thermo Fisher Scientific Inc. and CSL Limited recently announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies while also….
RISK-BASED MONITORING - Making the Move to RBM: Improving Patient Safety & Data Quality With Real-Time Insights May 4, 2020
Crystal Stone and Amanda Coogan indicate that in an era in which the time- and resource-intensive business model of developing blockbuster drugs has been supplanted by a push to move drug candidates through the pipeline with greater speed, accuracy, and quality, RBM and real-time data analytics are becoming a must-have for clinical trials.
OncoCyte Announces Agreement to Acquire Molecular Diagnostics Company January 15, 2020
OncoCyte Corporation recently announced it has entered into an agreement to acquire, through a subsidiary, all of the outstanding capital...Novavax Granted Fast-Track Designation January 15, 2020
Novavax, Inc. recently announced the US FDA has granted Fast-Track Designation for NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate,...PERSONALIZED MEDICINE - Personalizing Cancer Immunotherapy: Trends in Biomarker Discovery January 14, 2020
Emile Youssef, MD, PhD, says due to tumor heterogeneity, the plasticity and diversity of cancer cells, and a multitude of other factors, biomarker development is a challenge, and thus explores four trends in cancer biomarker discovery.
Ivy Brain Tumor Center & Salarius Pharmaceuticals Launch Collaborative Partnership August 26, 2019
The Ivy Brain Tumor Center at the Barrow Neurological Institute and Salarius Pharmaceuticals, Inc. recently announced a collaborative partnership to...Janssen Announces Collaboration to Expand Data Science Research in Healthcare June 25, 2019
Janssen Research & Development, LLC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), recently announced a collaboration...Caris Life Sciences Acquires Pharmatech May 1, 2019
Caris Life Sciences recently announced it has acquired Pharmatech, Inc., a pioneer of the original Just-In-Time research system with the largest research-ready oncology network.
AMORPHOUS SOLID DISPERSIONS - Increasing Solubility From API to Tablets April 1, 2019
Paulo Lino, PhD, and João Henriques discuss the main development goals and present a framework for a streamlined development of amorphous solid dispersion formulations by spray drying.
Quotient Sciences & Druggability Technologies Announce Collaboration December 11, 2018
Quotient Sciences and Druggability Technologies recently announced a collaboration to utilize Quotient’s integrated Translational Pharmaceutics platform to advance the development of DRGT-46, a novel, fast-acting formulation of celecoxib using proprietary super-API compositions developed by DRGT.
GSK to Acquire Oncology Focused Biopharmaceutical Company December 10, 2018
GlaxoSmithKline plc recently announced that the companies have entered into a definitive agreement pursuant to which GSK will acquire TESARO,...MedPharm Receives Growth Equity Investment From Ampersand Capital Partners March 27, 2018
MedPharm Ltd., a leading provider of contract topical and transdermal product design and formulation development services, recently announced a multi-million...Elligo Health Research & Saama Technologies Announce Strategic Partnership March 6, 2018
Elligo Health Research is partnering withSaama Technologies, Inc. to improve awareness of, access to, and participation in clinical trials for...R&D PARTNERSHIPS - Partnering for Progress: How Collaborations Are Fueling Biomedical Advances November 20, 2017
Neil Lesser and Matt Hefner analyze biopharmaceutical partnerships created throughout the past several decades, and based upon a comprehensive database of partnerships formed between 1980 and 2014, they found that R&D-focused partnerships have grown substantially.
ONCOLOGY DIAGNOSTICS - Advancements Paving the Way for More Tailored Drugs November 20, 2017
Divyaa Ravishankar, MS, says pharmaceutical companies have been subjected to a wide variety of external forces compelling them to get innovative about development of new platforms, liaise with new partners, leverage big data toward precision and predictive diagnosis, and identify new markers.
SPECIAL FEATURE - Platform Technologies - Derisking & Transforming Drug Development September 29, 2017
Contributor Cindy H. Dubin, in this second annual report, speaks with several exciting and innovative companies whose platform technologies are transforming drug development.
DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients August 8, 2017
DBV Technologies recently announced that the first patient has been enrolled in EPITOPE (EPIT in TOddlers with PEanut Allergy), a...Microneedles - A Novel Alternative in Selected Drug Delivery Areas June 29, 2017
Microneedles are a novel drug delivery technology that can offer promising advantages as an alternative to classical needle...GeneCentric Therapeutics Appoints New CBO; Advances Drug Development Platform June 6, 2017
GeneCentric Therapeutics, Inc. recently announced the appointments of Walter M. Capone as Chief Business Officer and Ellen Lubman to the...WHITEPAPER: Lonza Engine® & Xcelodose®: Accelerating Preclinical & Clinical Trial Pathways With Target Dosing Technologies
Learn how Lonza helps developers quickly assess new drug candidates while minimizing API consumption through efficient excipient screenings, encapsulation and...
